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1 Abstract 
Background: Apoptosis has been considered as an underlying mechanism in acute lung in-
jury (ALI) and acute respiratory distress syndrome (ARDS). Suggestions are now emerging to 
assume that similar cell types might experience different apoptosis degrees upon injury. En-
dotoxin-induced injury is an experimental in vitro and in vivo model closely resembling ALI 
and ARDS in humans. Additionally, it is known from previous studies that hypoxia can exert 
a pro-inflammatory effect on the lung.  
Methods: Apoptosis was determined in effector cells (alveolar macrophages, neutrophils) and 
target cells (tracheobronchial and alveolar epithelial cells) of the respiratory compartment, 
measuring caspase-3 activity, which is a crucial mediator of apoptosis. Cells were stimulated 
with lipopolysaccharide (LPS) for 4 h or cells were exposed to 5% oxygen for 4 h. Campto-
thecin was used a positive control for induction of apoptosis. 
Results: Apoptosis rate of alveolar macrophages was increased by 75% (p< 0.05) in the pres-
ence of LPS, while hypoxia did not affect caspase-3 activity. Neutrophils, however, showed a 
decreased apoptosis rate of 39% under hypoxia (p< 0.05). LPS did not change caspase-3 ac-
tivity in neutrophils. Tracheobronchial epithelial cells experienced an enhanced caspase-3 
activity upon LPS stimulation (increase of 121%, p< 0.05) with no change under hypoxia. 
Similar results were found in alveolar epithelial cells with a LPS-induced increase of apop-
tosis rate of 45% (p< 0.05) and an unaffected caspase-3 activity under hypoxia. 
Discussion: While alveolar macrophages, tracheobronchial and alveolar epithelial cells dem-
onstrated a similar pattern regarding changes of apoptosis rate upon injury, neutrophils react 
differently. The biological impact of this observation is under evaluation. Further experiments 
have to be performed to determine the possible pro- or anti-inflammatory role of apoptosis of 
cells in the respiratory compartment upon injury. 
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2 Introduction 
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) cause severe respi-
ratory failure and death in critically ill patients. The development of ALI/ARDS is associated 
with several clinical disorders including direct pulmonary injury from pneumonia and aspira-
tion as well as indirect pulmonary injury from trauma or sepsis. Additionally ventilatory sup-
port including mechanical stress on respiratory epithelial cells may also negatively affect lung 
tissue and contribute to the development of ALI/ARDS (1). Although knowledge about 
mechanisms leading to ALI/ARDS has increased, no specific and successful treatment options 
exist to date and thus the mortality rate remains high in patients with ALI/ARDS (2). 
The airway compartment with alveolar macrophages and epithelial cells as the predominant 
cell types is a physiological barrier to a variety of environmental agents including gases, par-
ticulates and microbes. An injury to lung tissue involving the airway compartment can lead to 
serious illness and life-threatening conditions such as ALI/ARDS. Alveolar macrophages are 
located at the air-tissue interface in the lung and are therefore the first cells, which interact 
with inhaled organisms and antigens (3). A central factor in the pathogenesis of inflammatory 
lung disease is the locally elevated number of alveolar macrophages. It has been shown in 
several lung injury models that activated pulmonary macrophages release cytokines as well as 
the chemokines (4, 5). All these inflammatory mediators together play a crucial role in the 
orchestration of an inflammatory response, particularly in neutrophil recruitment. Neutrophil 
sequestration and migration into alveoli remain pathohistological hallmarks of ARDS, with 
neutrophils being key effector cells, which further destruction of lung tissue (6). 
Lipopolysaccaride (LPS)-induced lung injury is a very useful experimental model for the in-
vestigation and characterization of those immunopathogenic changes and mechanisms in 
acute lung injury. LPS, a component of the outer membrane of gram negative bacteria, is ca-
pable of inducing severe lung injury. The response to LPS in the lung results in an acute in-
flammatory reaction regulated by the coordinated function of cytokines, chemokines and ad-
hesion molecules. 
The process of programmed cell death, or apoptosis is known to play a major regulatory role 
in maintaining many biologic processes, not least of which is the inflammatory response, such 
as in ALI/ARDS. Two major apoptosis pathways in mammalian cells are known so far: 1) the 
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intrinsic or mitochondrial pathway with involvement of Bcl-2 at the outer membrane of mito-
chondria and cytochrome c release 2) extrinsic or death receptor pathway with activation of 
caspase-8 upon binding of death activator to Fas- and TNF-receptor at the surface of the cell. 
Both pathways converge at the level of caspase-3 activation (7). Apoptosis results in destruc-
tion of proteins by caspases as well as in fragmentation of the DNA. Cell volume decreases 
and finally apoptotic cells are eliminated by phagocytes. Inappropriate activation or inhibition 
of apoptosis can lead to disease either because ‘undesired’ cells develop prolonged survival or 
because ‘desired’ cells die prematurely (8). 
Purpose of this study was to evaluate endotoxin and hypoxia-induced apoptosis rate of effec-
tor cells (alveolar macrophages and neutrophils) as well as target cells (tracheobronchial 
epithelial cells and alveolar epithelial cells).  
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3 Material and Methods 
Animals 
Specific pathogen-free male Wistar rats (250-300 g) were purchased from Janvier (Le Genest-
St. Isle, France). Rats were anesthetized with subcutaneously administered Hypnonorm® 
(fentanyl/fluonisone; Janssen, Beerse, Belgium) 0.25 ml/kg body weight, Domitor® (mede-
tomidine; Pfizer, Inc., Westchester, PA, USA) 0.25 ml/kg body weight and 0.1% atropine 
0.05 ml/kg body weight. All animal experiments and animal care were approved by the Swiss 
Veterinary Health Authorities. 
Alveolar macrophages 
Mac cells (CRL-2192, American Type Culture Collection, Rockville, MD) were established 
from normal Sprague-Dawley rat alveolar macrophage cells obtained by lung lavage, cloned 
and subcloned three times. The cells exhibit characteristics of macrophages and are sensitive 
to endotoxin. 
Isolation of neutrophils 
Human neutrophils (PMN) were isolated by gradient centrifugation over Ficoll-Paque (Amer-
sham Pharmacia Biotech, Dubendorf, Switzerland) followed by 1% dextran sedimentation for 
1 h to separate neutrophils from erythrocytes, as described previously (9). After centrifugation 
of the supernatant, contaminating erythrocytes were lysed with distilled water followed by the 
addition of 2.7% NaCl to stop hypotonic lysis. Neutrophils were washed with phosphate-
buffered saline (PBS) and resuspended at a total concentration of 2 x 106 PMN/ml in DMEM 
with 1% FBS. 
Isolation and culture of TBEC 
Trachea and bronchial parts of the respiratory system were excised, ligated at the distal ends, 
filled with 0.01% protease type XIV (Sigma, Buchs, Switzerland) and incubated overnight at 
4°C (10). TBEC were flushed out with fetal bovine serum (FBS), washed twice, and incu-
bated in airway epithelial cell basal medium (PromoCell) with 10% FBS in 96-well plates, 
previously coated with 50 µg/ml rat tail collagen (Sigma, Buchs, Switzerland) for 30 min at 
room temperature. Cells reached 100% confluency within 3 days. Purity was verified using 
periodic acid-Schiff staining (>98%). Epithelial cell character was also confirmed by a pa-
thologist at the University Hospital of Zurich. 
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Alveolar epithelial cells (AEC) 
L2 cells (CCL 149, American Type Culture Collection, Rockville, MD) are isolated cell lines 
derived through cloning of adult female rat lung of alveolar epithelial cell type II origin (11). 
The cells were cultured in Dulbecco’s modified Eagle’s Medium (DMEM; Invitrogen AG, 
Basel, Switzerland), supplemented with 10% fetal bovine serum (FBS), 1% penicillin-
streptomycin, and 1% HEPES buffer and grown in uncoated 96-well plates (Corning Inc., 
Corning, NY) to more than 95% confluence. Prior to cell stimulation, the medium was 
changed to DMEM with 1% FBS. 
Stimulation with LPS 
Cells were washed twice with warm phosphate-buffered saline (PBS) and incubated with LPS 
from Escherichia coli serotype 055:B5 (LPS; 20 µg/mL; Sigma-Aldrich, Buchs, Switzerland) 
(or PBS as a control) for 4 h at 37°C.  
Hypoxia 
A cell incubator (Bioblock, Ittigen, Switzerland) adjustable to different oxygen concentrations 
by insufflation of nitrogen (N2) was used as a hypoxic cell chamber. The concentrations were 
monitored continuously by an oxygen sensor. Experiments were performed with 5% oxygen 
and 5% CO2 at 37°C. For control cells, an incubator (Bioblock) with 21% O2, 5% CO2 at 
37°C was used. For our studies, L2 cells, Mac and isolated PMN were plated in 96-well tissue 
culture plates (Corning, New York, NY, USA) and exposed to 5% O2 for 4 h. 
 
Fluorometric assay for caspase-3 activity 
For the caspase assays, TBEC were isolated and grown to confluence in 96-well plates, as 
well as L2 and Mac and stimulated with LPS (20 µg/ml) or camptothecin (4 µM) for 4 h. Cas-
pase-3 activity was determined by measuring proteolytic cleavage of the fluorogenic caspase-
3 substrate Ac-Asp-Glu-Val-Asp-AMC (Merck, Darmstadt, Germany). Cells were incubated 
for 1 h at 37°C with 125 µM substrate. The fluorescence of the cleaved reporter group was 
measured at an excitation wavelength of 360 nm and an emission wavelength of 465 nm. 
Camptothecin (an extract of the Chinese tree Camptotheca acuminata) is a potent inhibitor of 
topoisomerase I, a molecule required for DNA synthesis. Camptothecin has been shown to 
induce apoptosis and was therefore used for positive controls. 
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Determination of lactate dehydrogenase 
Viability of cells was determined by the trypan blue dye exclusion assay. In addition, results 
were confirmed with a cytotoxicity assay (determination of lactate dehydrogenase) (Promega, 
Madison, WI) as described previously (12). 
Statistical analysis 
Results are expressed as means ± SEM. All experiments were conducted at least 3 times. 
ANOVA was performed to assess the statistical significance of differences. P values < 0.05 
were considered significant. 
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4 Results 
Hypoxia- and endotoxin-induced apoptosis in effector cells 
To determine a possible effect of hypoxia on apoptosis in alveolar macrophages and neutro-
phils, caspase-3 as the key enzyme in the final pathway was determined. Interestingly, the two 
cell types, although belonging to the group of effector cells, did not experience the same 
changes. While under hypoxic conditions apoptosis rate did not change in alveolar macro-
phages compared to control cells, caspase-3 activity increased by 75% in the LPS group (p< 
0.05) (Fig. 1). Neutrophils, however, showed less caspase-3 activity under hypoxia in com-
parison to control cells (39% decrease, p< 0.05). With LPS, neutrophils experienced no 
change in apoptosis rate (Fig. 2). 
Hypoxia- and endotoxin-induced apoptosis in target cells 
Hypoxia did not alter apoptosis rate in tracheobronchial epithelial cells. Stimulation with LPS 
increased caspase-3 activity by 121% (p< 0.05) (Fig. 3). Alveolar epithelial cells as possible 
target cells showed a similar apoptosis pattern as tracheobronchial epithelial cells and alveolar 
macrophages. Hypoxia did not induce changes in apoptosis rate in alveolar epithelial cells, 
while LPS increased caspase-3 activity (45%, p< 0.05) (Fig. 4). 
Hypoxia- and endotoxin-induced cell death in effector cells 
Cell death rate was determined to first exclude an interference with the apoptosis results and 
second to evaluate the direct effect of hypoxia and endotoxin, respectively, on cell death. 
Spontaneous cell death in alveolar macrophages after a 4 h incubation rate was 22% (Fig. 5). 
Similar results were found in these cells under hypoxia and LPS with no statistically signifi-
cant differences compared to control cells. In neutrophils, basal death rate was 20% with no 
changes under different conditions (Fig. 6). 
Hypoxia- and endotoxin-induced cell death in target cells 
Tracheobronchial epithelial cells had a spontaneous death rate of 27% (Fig. 7). But also in 
these cells, death rate was not altered under hypoxia or LPS. Similar results were found for 
alveolar epithelial cells with no change in cell death rate upon injury (Fig. 8). 
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5 Discussion 
Numerous studies have been conducted to better understand ALI/ARDS. Cell death has been 
demonstrated to play a key role in the lung during the pathogenesis of ALI/ARDS. In this 
study we focused on different cell types of the respiratory compartment and determined apop-
tosis and necrosis in vitro in the model of hypoxia- or endotoxin-induced injury. While alveo-
lar macrophages, alveolar epithelial cells, and tracheobronchial epithelial cells showed the 
same apoptosis pattern with increased apoptosis rate under stimulation with LPS and no 
change upon hypoxic condition, an attenuated apoptosis rate was seen in neutrophils under 
hypoxia and no change after stimulation with endotoxin.  
Programmed cell death is a process by which cells ‘commit suicide’ through apoptosis or 
other alternative pathways. Cell death occurs at a specific point in the developmental process 
and is therefore considered as ‘programmed’. It can also be triggered by external stimuli, such 
as soluble cell death ligands, which are released during inflammatory responses, or intrinsic 
stimuli, resulting from alteration of cellular function and metabolism. Apoptosis is character-
ized by cell shrinkage and formation of apoptotic bodies. Various biochemical features of 
apoptosis have been identified, which have been used frequently as an indication for apop-
tosis, such as caspase activaion, DNA fragmentation, and externalization of phosphatidylser-
ine, a cell surface marker for phagocytosis (7). Caspases are the most extensively studied pro-
teases that are activated during apoptosis. They exist as inactive protease precursors within 
cells and can be activated by themselves or by other proteases.  Both an intrinsic and extrinsic 
pathway end up with activation of caspase-3. 
LPS has been commonly used as a tool to study the mechanisms of ALI in cultured cells and 
in animals. In a model of LPS administration in mice, extended apoptosis was observed in 
vascular endothelial cells, but also in epithelial cells (13). Our results support these findings 
with increased apoptosis rate in epithelial cells. Caspase activity of neutrophils, however, was 
not changed upon LPS stimulation at this early time point of injury. Interestingly, a recent 
study showed that neutrophil apoptosis seems to be inhibited in patients with ALI/ARDS (14). 
In a different model of ALI, induced by intravascular injection of oleic acid to simulate pul-
monary fat embolism-induced ALI, at 1 and 4 h following oleic acid injection a massive neu-
trophil response was found in the lung, without any evidence of apoptosis. 24 h later, in the 
early resolution stage, intense neutrophil apoptosis was observed (15). Therefore, it might be 
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concluded that neutrophils experience a different apoptosis response than the other cells of the 
respiratory compartment at this early time point of injury. Alveolar macrophages, however, 
seem to have a similar reaction pattern as epithelial cells (16). As previously described, 
among the different bacterial cell wall components, LPS seems to be the only inducer of 
apoptosis in human alveolar macrophages. 
Under hypoxic conditions apoptosis rate of epithelial cells and alveolar macrophages did not 
change. Again, neutrophils experience a different reaction regarding apoptosis rate compared 
to the other cell types. Hypoxia decreased caspase-3 activity in neutrophils. Current data indi-
cate that many factors operating at the inflamed site as hypoxia and acidosis serve a dual 
function in both priming and activating neutrophils and delay apoptosis (17). 
Hypoxic or endotoxin-induced injury did not induce cell death in all cell types. This observa-
tion might not be surprising as 4 hours of stimulation are rather short. Necrosis might be con-
sidered as the common destiny of cell death, therefore also for apoptosis. The routes of cell 
death could be interrelated based on underlying mechanisms and conditions (18). Taking this 
concept into account, one should pay more attention to the pathways such as apoptosis that 
eventually lead to necrosis. The concept may help to explain why blocking these earlier states 
of cell death may improve the organ function by preventing necrosis. 
In conclusion, our data show, that the three cell types from the respiratory compartment al-
veolar and trachebronchial epithelial as well as alveolar macrophages show the same pattern 
of apoptosis upon exposure to hypoxia and endotoxin. The apoptotic answer of neutrophils, 
however, is different. The functional implications of these inflammatory answers have further 
to be analyzed. 
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7 Figure Legend 
Figure 1 
Determination of apoptosis rate in alveolar macrophages. Caspase-3 activity was measured in 
control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml lipopolysaccharide (LPS) 
for 4 h. Camptothecin was used as a positive control for apoptosis. Values are mean +/- SEM 
from 5 experiments. 
* P< 0.05 between control and hypoxia.  
Figure 2 
Determination of apoptosis rate in neutrophils. Caspase-3 activity was measured in control 
cells, after exposure to 5% oxygen, or exposure to 20 µg/ml lipopolysaccharide (LPS) for 4 h. 
Camptothecin was used as a positive control for apoptosis. Values are mean +/- SEM from 5 
experiments.  
* P< 0.05 between control and LPS.  
Figure 3 
Determination of apoptosis rate in tracheobronchial epithelial cells. Caspase-3 activity was 
measured in control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml lipopolysac-
charide (LPS) for 4 h. Camptothecin was used as a positive control for apoptosis. Values are 
mean +/- SEM from 5 experiments.   
* P< 0.05 between control and LPS.  
Figure 4 
Determination of apoptosis rate in alveolar epithelial cells. Caspase-3 activity was measured 
in control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml lipopolysaccharide 
(LPS) for 4 h. Camptothecin was used as a positive control for apoptosis. Values are mean +/- 
SEM from 5 experiments.   
* P< 0.05 between control and LPS.  
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Figure 5 
Cell death rate in alveolar macrophages. Lactate dehydrogenase (LDH) activity was measured 
in supernatants of control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml 
lipopolysaccharide (LPS) for 4 h. Some wells were lysed to determine 100% release of LDH. 
LDH in supernatants was correlated to total LDH. Camptothecin was used as a positive con-
trol for apoptosis. Values are mean +/- SEM from 5 experiments.  
Figure 6 
Cell death rate in alveolar neutrophils. Lactate dehydrogenase (LDH) activity was measured 
in supernatants of control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml 
lipopolysaccharide (LPS) for 4 h. Some wells were lysed to determine 100% release of LDH. 
LDH in supernatants was correlated to total LDH. Camptothecin was used as a positive con-
trol for apoptosis. Values are mean +/- SEM from 5 experiments.  
Figure 7 
Cell death rate in tracheobronchial epithelial cells. Lactate dehydrogenase (LDH) activity was 
measured in supernatants of control cells, after exposure to 5% oxygen, or exposure to 20 
µg/ml lipopolysaccharide (LPS) for 4 h. Some wells were lysed to determine 100% release of 
LDH. LDH in supernatants was correlated to total LDH. Camptothecin was used as a positive 
control for apoptosis. Values are mean +/- SEM from 5 experiments. 
Figure 8 
Cell death rate in alveolar epithelial cells. Lactate dehydrogenase (LDH) activity was meas-
ured in supernatants of control cells, after exposure to 5% oxygen, or exposure to 20 µg/ml 
lipopolysaccharide (LPS) for 4 h. Some wells were lysed to determine 100% release of LDH. 
LDH in supernatants was correlated to total LDH. Camptothecin was used as a positive con-
trol for apoptosis. Values are mean +/- SEM from 5 experiments.  
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